GFI1 Gene Neutropenia Nonimmune Chronic Idiopathic of Adults NGS Genetic DNA Test
Comprehensive Genetic Analysis for Chronic Neutropenia
The GFI1 Gene Neutropenia Nonimmune Chronic Idiopathic of Adults NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals suffering from unexplained chronic neutropenia. This advanced genetic test specifically targets mutations in the GFI1 (Growth Factor Independent 1) gene, which plays a critical role in neutrophil development and function. Chronic idiopathic neutropenia affects approximately 1 in 1,000,000 individuals and can lead to serious health complications if left undiagnosed and untreated.
What This Test Measures and Detects
Our state-of-the-art NGS genetic testing platform comprehensively analyzes the GFI1 gene to identify:
- Pathogenic mutations affecting neutrophil production
- Genetic variants associated with chronic idiopathic neutropenia
- Inheritance patterns for family risk assessment
- Specific genetic markers that influence treatment response
- Novel mutations that may not be detected by conventional testing methods
Who Should Consider This Genetic Test
This specialized genetic test is recommended for individuals experiencing:
- Persistent low neutrophil counts (below 1500 cells/μL) for more than 3 months
- Recurrent bacterial infections without identifiable cause
- Family history of neutropenia or blood disorders
- Unexplained fever episodes and oral ulcers
- Poor response to conventional neutropenia treatments
- Diagnostic uncertainty despite extensive hematological workup
Clinical Benefits of GFI1 Genetic Testing
Undergoing GFI1 gene testing provides numerous clinical advantages:
- Accurate Diagnosis: Confirms genetic basis of neutropenia, eliminating diagnostic uncertainty
- Personalized Treatment: Guides appropriate therapeutic interventions based on genetic profile
- Family Planning: Enables informed reproductive decisions and genetic counseling
- Proactive Management: Facilitates early intervention to prevent serious infections
- Comprehensive Care: Integrates findings into multidisciplinary treatment approach
Understanding Your Test Results
Our comprehensive genetic counseling service helps you interpret your results:
- Positive Result: Identifies specific GFI1 mutation, confirming genetic diagnosis
- Negative Result: Rules out GFI1-related neutropenia, directing further investigation
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Identifies individuals who may pass the condition to offspring
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | GFI1 Gene Neutropenia Nonimmune Chronic Idiopathic of Adults NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Pre-Test Requirements
Before scheduling your test, please ensure:
- Complete clinical history documentation
- Genetic counseling session to create family pedigree chart
- Review of previous hematological investigations
- Discussion of potential implications for family members
Nationwide Testing Availability
We have conveniently located testing centers across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality genetic testing services nationwide.
Take Control of Your Health Today
Don’t let unexplained neutropenia compromise your quality of life. Our specialized genetic testing provides the answers you need for proper diagnosis and management. Contact our genetic counselors today to schedule your test and begin your journey toward better health.
Call or WhatsApp us at +1(267) 388-9828 to book your GFI1 Gene Neutropenia Test today!
Our team of genetic specialists, hematologists, and immunologists are ready to provide comprehensive care and support throughout your testing journey. Early genetic diagnosis can significantly improve outcomes and quality of life for individuals with chronic idiopathic neutropenia.
